A new drug for cancer introduced in 2014 costs about six times the price of a new drug in 2000, with the cost of many other drugs to treat the disease increasing in price significantly during that time, according to a new study.
Researchers at the University of North Carolina found the skyrocketing prices line up with changes in health insurance making patients responsible for more of the cost and potentially put people in the position of not being able to afford treatment.
Cost for new oral cancer drugs skyrocketed in last decade
What’s for Breakfast? How About Some Monsanto Weed Killer?
Just how much of Monsanto’s most popular weed killer are you eating every morning for breakfast?
In an unsettling report released Tuesday by the Alliance for Natural Health, the nonprofit advocacy group details the results of a study that shows a host of breakfast foods—from cereal to eggs to coffee creamer—contain residues of glyphosate, the chemical herbicide more commonly known by Monsanto’s trade name for it, Roundup.
The report comes one year after the cancer-research arm of the World Health Organization made headlines by classifying glyphosate, which has long been regarded by U.S. regulators as posing little risk to public health, as a probable human carcinogen.
A subtype of thyroid tumor isn’t cancer after all
People diagnosed with a particular type of thyroid cancer and aggressively treated for it actually didn’t have cancer after all.
That’s the conclusion of 24 endocrinology pathologists from seven countries empaneled by the University of Pittsburgh School of Medicine to reconsider the diagnosis and treatment of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma.
Ex-NFL Players Rally Behind Medical Marijuana
Thirty ex-NFL players have teamed up with a cannabis company in California to test medical marijuana as a treatment for chronic pain and depression. The move comes in the wake of increasing reports on the physical and mental anguish retired football players face, including a potentially debilitating brain disease called chronic traumatic encephalopathy (CTE). Is this the answer they’ve been looking for?
Leading the player side of the trial is Gridiron Cannabis Coalition, an organization founded by a former NFL star to spread awareness about the effectiveness of the drug. Longstanding marijuana extract maker Constance Therapeutics will provide the extracts and oils that players will use to treat their pain.
Obamacare to launch new payment initiative
Six years after President Obama’s health reforms became law, officials in his administration told POLITICO they are launching the largest-ever initiative to transform primary care in America, an effort to give doctors more flexibility and reward them for producing better results for their patients.
The experiment the administration will announce today, a program called Comprehensive Primary Care Plus, is intended to shake up the way 20,000 doctors and clinicians treat more than 25 million patients when it goes into effect in January 2017.
Abortion without the clinic on offer with revolutionary new US program
A groundbreaking new experiment is launching in four states that could make abortion dramatically more accessible by allowing women to obtain abortion-inducing drugs through the mail.
The program, which will be run as a pilot study out of four clinics in New York, Hawaii, Oregon and Washington state, is a first in the US – and one that its architects urgently hope to expand as the country’s abortion clinics close down at historic rates.
Drug company hikes price for end-of-life drug Seconal
The 80-year-old drug Seconal, a once widely used sleeping pill now often prescribed as an end-of-life treatment, has doubled in price as laws go into effect in several states this year permitting terminally ill patients to take their own lives.
Valeant Pharmaceuticals, which is among companies being investigated by Congress for price gouging, doubled the price of Seconal last year from $1,500 to $3,000 after acquiring the rights to it.
More Articles...
Page 23 of 233